Fig. 2From: Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 studySurvival curves. Event-free (EFS) (a), progression-free (PFS) (b, c), and overall survival (OS) (d) with respect to biomarker expressionBack to article page